Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History NLSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics NLSP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

NLS Pharmaceutics AG

NLSP
Current price
2.22 USD -0.03 USD (-1.33%)
Last closed 2.25 USD
ISIN CH0523961370
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 11 043 068 USD
Yield for 12 month -69.20 %
1Y
3Y
5Y
10Y
15Y
NLSP
21.11.2021 - 28.11.2021

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience for the treatment of narcolepsy; and Nolazol for the treatment of ADHD. The company also develops NLS-4, a selective dopamine reuptake inhibitor treatment for the chronic fatigue associated with the symptoms of Long-COVID; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist for improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. It has licensing agreements with Pegasus Advanced Research for use of mazindol for the treatment of ADHD. NLS Pharmaceutics AG was incorporated in 2015 and is headquartered in Zurich, Switzerland. Address: The Circle 6, Zurich, Switzerland, 8058

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.00 USD

P/E Ratio

Dividend Yield

Financials NLSP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures NLSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-11 408 USD

Current Quarter

-5 704 USD

Last Quarter

-5 704 USD
EBITDA -3 632 954 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -111.41 %
PEG Ratio
Return On Equity TTM -862.92 %
Wall Street Target Price 6.00 USD
Revenue TTM
Book Value -0.42 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.63 USD
Diluted Eps TTM -2.63 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation NLSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.02
Price Book MRQ 4.84

Technical Indicators NLSP

For 52 Weeks

1.30 USD 15.59 USD
50 Day MA 2.13 USD
Shares Short Prior Month 72 299
200 Day MA 2.51 USD
Short Ratio 0.15
Shares Short 177 183
Short Percent 1.61 %